toespraak

FINAL PROGRAMME

For all abstract texts (orals and posters) click here

To view posters click here

Conference paper prize, contest for all authors: click here

 

Thursday Sept 19
Pre-conference workshop: Monitoring and Evaluation of Newborn Screening Programmes                   Chair: Joanne Mei/Gerard Loeber
0900 Welcome Dianne Webster (New Zealand)
0905 -1020 Monitoring the screening pathway
0905 - 0910 Introduction: what is the screening pathway Dianne Webster (New Zealand)
0910 - 0930 Monitoring the screening pathway a national approach Christine Cavanagh (UK)
0930 - 0945 Key performance indicators of the screening for congenital hypothyroidism Sri Lanka in terms of coverage, effectiveness of detection and managing cases Manjula Hettiarachchi (Sri Lanka)
0945 -1000 Detecting Missed Cases of Congenital Hypothyroidism During Repeat Newborn Screening of Preterm Babies Conchita Abarquez (Philippines)
1000 -1020 Describing programme data Stats 101 Jose Derraik (New Zealand)
1020 -1040 Tea/coffee break
1040 - 1235 Monitoring in the laboratory
1040 - 1055 Importance of sample quality Enzo Ranieri (Australia)
1055 - 1115 Single standard for Sample quality in the UK Jim Bonham (UK)
1115 - 1135 Assay comparison and monitoring Veronica Wiley (Australia)
1135 – 1155 The value of laboratory accreditation and linking ISO15189 to practical issues in the delivery of screening Jim Bonham (UK)
1155 – 1215 China lab accreditation Lin Zou (P.R.China)
1215 – 1235 Incident reporting and the value of incidents to improve screening practice Christine Cavanagh (UK)
1235 - 1315 Lunch
1315 - 1425 Monitoring in the laboratory (contd.)
1315 -1335 Determining monitoring and validating cutoffs Veronica Wiley (Australia)
1335 -1350 Utilizing a national data system for newborn screening improvement Ma Elouisa Reyes (Philippines)
1350 -1410 PEAS Brad Therrell (USA)
1410 -1425 Philippine PEAS: Over 15 years of experience in program monitoring and evaluation Karen Asuncion Panol (Philippines)
1425 -1515 Outcome and programme evaluation
1425 -1435 Importance of definitions Dianne Webster (New Zealand)
1435 -1515 Design and evaluation of outcome studies Jose Derraik (New Zealand)
1515 Closure
1600 - 1630 Chairperson meeting
1700 - 1725 Opening ceremony Chair Jim Bonham (ISNS)
Welcome speech China Health
Welcome speech China Hospital
Welcome speech China University
Welcome speech Meeting President
Welcome speech ISNS President
1725 - 1810 30 years of Newborn Screening in China Zhengyan Zhao (China)
1810 - Welcome mixer
Friday Sept 20
0730 – 0830 ISNS Council Breakfast meeting
0830 - 1000 Session 1 Current status of worldwide screening Chair: Zhengyan Zhao / Rodney Howell
0830 - 0845 Latin America Gustavo Borrajo (Argentina)
0845 - 0900 North America Jelili Ojodu (USA)
0900 - 0915 Europe Gerard Loeber (Netherlands)
0915 - 0930 Middle East / North Africa Issam Khneisser (Lebanon)
0930 - 0945 Asia-Pacific Enzo Ranieri (Australia)
0945 - 1000 G6PD Newborn Screening Overview Issam Khneisser (Lebanon)
1000 - 1030 Tea/coffee break
1030 - 1200 Session 2 Newborn Screening Systems and Pathways Chair: Jun Zhu / Carmen Padilla
1030 - 1100 Public Health Perspective of Screening Gary Jackson (New Zealand)
1100 - 1130 Newborn Screening System Dianne Webster (New Zealand)
1130 - 1200 Newborn Screening Pathway Jim Bonham (UK)
1200 - 1330 Lunch and Trade Sponsored Seminar (see Note 1 below)
1330 - 1530 Session 3 Starting programmes and increasing coverage and range of disorders Chair: Yanling Yang / Issam Khneisser
1330 - 1400 Starting Programmes Seema Kapoor (India)
1400 - 1430 Increasing Coverage - Improvement, Problems and Challenges Carmen Padilla (Philippines)
1430 - 1445  The Present Status of Congenital Hypothyroidism Screening in Bangladesh Mohammad Anwar-Ul-Azim (Bangladesh)
1445 - 1500 Newborn Screening - An Indian Perspective Ashok Gupta (India)
1500 - 1515 Newborn Screening for New Disorders in Developing Countries: Treatment Challenges Victor Skrinska (Qatar)
1515 - 1545 Afternoon Tea
1545 - 1730 Awards Ceremony: Guthrie, Dussault and Loeber awards Chair: Rodney Howell (USA)
Saturday Sept 21
0830 - 1000 Session 4 Screening for Specific Conditions Chair: Rulai Yang / Joanne Mei
0830 - 0850 NBS from Biochemical to Genetic Xuefan Gu (China)
0850 - 0910 Challenge of genotyping all detected cases in NBS in the NBS lab Toshiyuki Fukao (Japan)
0910 - 0930 Next Generation Sequencing in Newborn Screening in the United Kingdom National Health Service Rebecca Thomas (UK)
0930 - 0945 A cohort study of 300 Chinese patients with isolated methylmalonic aciduria Lulu Kang (China)
0945 - 1000 High-Throughput Identification of Hemoglobinopathies & Thalassemias by HRAM/MS Zoltan Lukacs (Germany)
1000 - 1015 Updates to NBS01 Version 7: Blood Collection on Filter Paper for Newborn Screening Programs Joanne Mei (USA)
1015 - 1045 Tea/coffee break
1045 - 1300 Session 5 New Conditions Chair: Lin Zou / Jim Bonham
1045 - 1115 Cost utility of a proposed additional disorder Gary Jackson (New Zealand)
1115 - 1135 Screening for spinal muscular atrophy (SMA) in NSW, Australia Veronica Wiley (Australia)
1135 - 1155 Validation of a Multiplexed Real-time PCR Assay to Detect SCID and SMN1 Homozygous Exon 7 Deletion and Droplet Digital PCR Assay to Assess SMN2 Copy Numbers in Newborn Screening for Spinal Muscular Atrophy Mei Baker (USA)
1155 - 1215 Newborn Screening for Severe Combined Immunodeficiency: Wisconsin Experience Mei Baker (USA)
1215 - 1230 Newborn Screening for Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency and Molecular Characterization of SLC25A13 gene in Guangzhou population Chengfang Tang (China)
1230 - 1245 Newborn Screening for DMD Fan Tong (China)
1245 - 1300 Tandem Mass Spectrometry for Newborn Screening of Lysosomal Storage Disorders and Beyond Michael Gelb (USA)
1300 - 1415 Lunch and Trade Sponsored Seminar (see Note 2 below)
1415 - 1515 ISNS AGM
1515 - 1800 Session 6 Poster Session
Chair: Xuefan Gu / Veronica Wiley
1515 - 1535 Best Posters Speed Dating
1535 - 1700 Poster viewing
1800 - Conference dinner
Sunday Sept 22
Session 7 Programme quality – evaluation Chair: Zhiguo Wang/Enzo Ranieri
0830 - 0900 Introduction and summary of pre-conference workshop Jose Derraik (New Zealand)
0900 - 0920 Laboratory quality evaluation Joanne Mei (USA)
0920 - 0940 Evaluation of CAH screening Junfen Fu (China)
0940 - 1000 Cystic Fibrosis screening - what is a missed case? Natasha Heather (New Zealand)
1000 - 1030 Tea/coffee break
1030 - 1130 Session 8 Point of Care Screening Chair: Rulai Yang/Dianne Webster
1030 - 1055 Newborn Screening for Critical Congenital Heart Disease Annamarie Saarinen (USA)
1055 - 1115 Newborn Pulse Oximetry Screening in China: An Integrated Public Health + Public Policy Approach Guoying Huang (China)
1115 - 1130 Philippine Multicenter Pulse Oximetry Screening for Critical Congenital Heart Disease (CCHD): A Preliminary Report Carmen Padilla (Philippines)
1130 - 1245 Session 9 Looking into the Crystal Ball - the future of newborn screening Chair: Guoying Huang/Gerard Loeber
1130 - 1150 Learning from the past going forward Rodney Howell (USA)
1150 - 1215 Pandora’s jar in a crystal ball. Peter Schielen (Netherlands)
1215 - 1245 Really inside the crystal ball John Christodoulou (Australia)
1245 Closing Ceremony Zhengyan Zhao and Jim Bonham
1300-1400 ISNS Council meeting

Note 1: PerkinElmer Lunch Symposium - Innovating for a healthier future
- Experiences using QSight® 210 MD system with NeoBase™ 2 MSMS kit – Maria Anna Messina, Italy
- Newborn screening pilot for Duchenne Muscular dystrophy (DMD) using GSP CK-MM kit as first tier and NGS for confirmatory testing — Veronica Wiley, Australia  

Note 2: Waters Lunch Symposium - FIA Dried Spot Analysis, reducing variability, improving reliability and efficiently integrating with clinical LIMS
- Manufacturer's approach –
Heather Brown,  Waters Corporation , UK
- Software support –
Alex Anderson, ISS-Omnilab, UK

 

/